71.96USD-3.23%Mkt Cap: 3.09B $P/E: —1d ago
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individ…
Industry Peers
Diagnostics & Research$201.86BUSDP/E 29.8
$145.10BUSDP/E 39.7
$45.85BUSDP/E 44.2
$45.44BUSDP/E 42.4
$38.64BUSD
$38.44BUSDP/E 27.3
$37.13BUSDP/E 48.1
$35.13BUSDP/E 26.2
$28.78BUSDP/E 34.6
$26.98BUSDP/E 31.4
$23.18BUSDP/E 23.1
$23.12BUSDP/E 25.0
$20.55BUSD
$15.36BUSDP/E 33.9
$13.06BUSDP/E 27.3
$12.46BUSDP/E 53.7
$11.04BUSD
$9.26BUSDP/E 21.6
$5.90BUSDP/E 237.4
$5.68BUSD
$5.21BUSDP/E 44.6
$4.95BUSD
$4.73BUSDP/E 54.8
$3.75BUSDP/E 26.5
$3.54BUSD
$2.08BUSD
$1.93BUSD
$1.83BUSD
$1.64BUSDP/E 41.7
$1.63BUSD
$1.48BUSDP/E 22.4
$1.02BUSDP/E 21.4
$898.56MUSD
$734.89MUSD
$616.40MUSDP/E 40.2
$584.63MUSD
$583.63MUSD
$293.12MUSDP/E 2.9
$292.75MUSD
$206.70MUSD
$152.09MUSD
$139.43MUSD
$97.25MUSD
$102.68MUSD
$89.37MUSDP/E 17.2
$73.19MUSD
$58.55MUSD
$42.32MUSD
$30.71MUSD
$26.61MUSD
$20.94MUSD
$16.60MUSD
$12.04MUSD
$9.95MUSD
$8.70MUSD
$8.87MUSD
$7.73MUSD
$7.43MUSD
$6.69MUSD
$6.06MUSD
$5.06MUSD
$4.47MUSD
$4.44MUSD
$2.95MUSD
$3.29MUSD
$3.18MUSD
$869.0KUSD
$314.2KUSDP/E Infinity
$19.6KUSD
Indicators:|
Key Statistics
Company
Market Cap3.09B $
Enterprise Value2.42B $
Revenue (TTM)156.12M $
Gross Profit-62.57M $
Net Income (TTM)-408.35M $
Revenue/Share4.072 USD
Last Price71.96 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees910
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.41
PEG—
EV/EBITDA-6.71
EV/Revenue15.50
P/S19.78
P/B1.18
EPS (TTM)-10.30
EPS (Forward)-9.72
52W Range
29.9547% of range118.84
52W High118.84 USD
52W Low29.95 USD
Profitability
Gross Margin-42.52%
Oper. Margin-332.88%
EBITDA Margin-230.91%
Profit Margin-277.47%
ROE-15.84%
ROA-13.97%
Growth
Revenue Growth28.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-299.01M $
CapEx (TTM)909.00K $
FCF Margin-69.02%
FCF Yield-3.49%
Net Debt-772.08M $
Net Debt/EBITDA2.14
Balance Sheet
Debt/Equity0.02
Current Ratio11.74
Quick Ratio11.29
Book Value/Sh60.79 USD
Cash/Share19.18 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.1 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)70.13 USD
Upside (mean)-2.6%
Target Range56.00 USD – 88.00 USD
$56.00-2.6% to mean$88.00
# Analysts8
Ownership
Shares Out.42.92M
Float33.47M
Insiders5.23%
Institutions83.52%
Short Interest
Short Ratio9.2d
Short % Float18.37%
Short % Out.18.06%
Shares Short7.75M
Short (prev mo.)6.36M
Technical
SMA 5064.69 (+11.2%)
SMA 20073.93 (-2.7%)
Beta3.22
S&P 52W Chg20.25%
Avg Vol (30d)598.06K
Avg Vol (10d)503.68K
Technical Indicators
RSI (14)58.7
MACD2.8956
MACD Signal2.4454
MACD Hist.+0.4502
BB Upper77.46 USD
BB Middle67.62 USD
BB Lower57.79 USD
BB Width29.09%
ATR (14)4.288 USD
Vol Ratio (20d)0.79x